Literature DB >> 27149205

Update: Ongoing Zika Virus Transmission - Puerto Rico, November 1, 2015-April 14, 2016.

Emilio Dirlikov, Kyle R Ryff, Jomil Torres-Aponte, Dana L Thomas, Janice Perez-Padilla, Jorge Munoz-Jordan, Elba V Caraballo, Myriam Garcia, Marangely Olivero Segarra, Graciela Malave, Regina M Simeone, Carrie K Shapiro-Mendoza, Lourdes Romero Reyes, Francisco Alvarado-Ramy, Angela F Harris, Aidsa Rivera, Chelsea G Major, Marrielle Mayshack, Luisa I Alvarado, Audrey Lenhart, Miguel Valencia-Prado, Steve Waterman, Tyler M Sharp, Brenda Rivera-Garcia.   

Abstract

Zika virus is a flavivirus transmitted primarily by Aedes species mosquitoes, and symptoms of infection can include rash, fever, arthralgia, and conjunctivitis (1).* Zika virus infection during pregnancy is a cause of microcephaly and other severe brain defects (2). Infection has also been associated with Guillain-Barré syndrome (3). In December 2015, Puerto Rico became the first U.S. jurisdiction to report local transmission of Zika virus, with the index patient reporting symptom onset on November 23, 2015 (4). This report provides an update to the epidemiology of and public health response to ongoing Zika virus transmission in Puerto Rico. During November 1, 2015-April 14, 2016, a total of 6,157 specimens from suspected Zika virus-infected patients were evaluated by the Puerto Rico Department of Health (PRDH) and CDC Dengue Branch (which is located in San Juan, Puerto Rico), and 683 (11%) had laboratory evidence of current or recent Zika virus infection by one or more tests: reverse transcription-polymerase chain reaction (RT-PCR) or immunoglobulin M (IgM) enzyme-linked immunosorbent assay (ELISA). Zika virus-infected patients resided in 50 (64%) of 78 municipalities in Puerto Rico. Median age was 34 years (range = 35 days-89 years). The most frequently reported signs and symptoms were rash (74%), myalgia (68%), headache (63%), fever (63%), and arthralgia (63%). There were 65 (10%) symptomatic pregnant women who tested positive by RT-PCR or IgM ELISA. A total of 17 (2%) patients required hospitalization, including 5 (1%) patients with suspected Guillain-Barré syndrome. One (<1%) patient died after developing severe thrombocytopenia. The public health response to the outbreak has included increased laboratory capacity to test for Zika virus infection (including blood donor screening), implementation of enhanced surveillance systems, and prevention activities focused on pregnant women. Vector control activities include indoor and outdoor residual spraying and reduction of mosquito breeding environments focused around pregnant women's homes. Residents of and travelers to Puerto Rico should continue to employ mosquito bite avoidance behaviors, take precautions to reduce the risk for sexual transmission (5), and seek medical care for any acute illness with rash or fever.

Entities:  

Mesh:

Year:  2016        PMID: 27149205     DOI: 10.15585/mmwr.mm6517e2

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  21 in total

1.  Implementation and Evaluation of Guillain-Barré Syndrome Surveillance in Puerto Rico during the 2016 Zika Virus Epidemic.

Authors:  Chelsea G Major; Emilio Dirlikov; Nicole A Medina; Roberta Lugo-Robles; Desiree Matos; Jorge Muñoz-Jordán; Candimar Colón-Sánchez; Myriam García-Negrón; Marangely Olivero-Segarra; Graciela Malavé-González; Dana L Thomas; Carlos A Luciano; Stephen H Waterman; James Sejvar; Tyler M Sharp; Brenda Rivera-García
Journal:  P R Health Sci J       Date:  2018-12       Impact factor: 0.705

2.  Zika Virus Infection Associated With Severe Thrombocytopenia.

Authors:  Tyler M Sharp; Jorge Muñoz-Jordán; Janice Perez-Padilla; Melissa I Bello-Pagán; Aidsa Rivera; Daniel M Pastula; Jorge L Salinas; Jose H Martínez Mendez; Mónica Méndez; Ann M Powers; Stephen Waterman; Brenda Rivera-García
Journal:  Clin Infect Dis       Date:  2016-07-14       Impact factor: 9.079

3.  Zika virus epidemic in Brazil. I. Fatal disease in adults: Clinical and laboratorial aspects.

Authors:  Raimunda S S Azevedo; Marialva T Araujo; Arnaldo J Martins Filho; Consuelo S Oliveira; Bruno T D Nunes; Ana C R Cruz; Ana G P A C Nascimento; Rita C Medeiros; Cezar A M Caldas; Fernando C Araujo; Juarez A S Quaresma; Barbara C B Vasconcelos; Maria G L Queiroz; Elizabeth S Travassos da Rosa; Daniele F Henriques; Eliana V P Silva; Jannifer O Chiang; Lívia C Martins; Daniele B A Medeiros; Juliana A Lima; Márcio R T Nunes; Jedson F Cardoso; Sandro P Silva; Pei-Yong Shi; Robert B Tesh; Sueli G Rodrigues; Pedro F C Vasconcelos
Journal:  J Clin Virol       Date:  2016-11-05       Impact factor: 3.168

Review 4.  Diagnosis of Zika Virus Infections: Challenges and Opportunities.

Authors:  Jorge L Munoz-Jordan
Journal:  J Infect Dis       Date:  2017-12-16       Impact factor: 5.226

Review 5.  Zika virus disease for neurologists.

Authors:  Daniel E Smith; J David Beckham; Kenneth L Tyler; Daniel M Pastula
Journal:  Neurol Clin Pract       Date:  2016-12

6.  Zika Virus Infection of the Human Glomerular Cells: Implications for Viral Reservoirs and Renal Pathogenesis.

Authors:  Donald J Alcendor
Journal:  J Infect Dis       Date:  2017-07-15       Impact factor: 5.226

7.  Detecting Local Zika Virus Transmission in the Continental United States: A Comparison of Surveillance Strategies.

Authors:  Steven Russell; Kyle Ryff; Carolyn Gould; Stacey Martin; Michael Johansson
Journal:  PLoS Curr       Date:  2017-11-22

8.  A Comprehensive Systems Biology Approach to Studying Zika Virus.

Authors:  Meghan May; Ryan F Relich
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

Review 9.  Zika virus: Epidemiology, current phobia and preparedness for upcoming mass gatherings, with examples from World Olympics and Pilgrimage.

Authors:  Nahla Khamis Ibrahim
Journal:  Pak J Med Sci       Date:  2016 Jul-Aug       Impact factor: 1.088

Review 10.  Zika Fetal Neuropathogenesis: Etiology of a Viral Syndrome.

Authors:  Zachary A Klase; Svetlana Khakhina; Adriano De Bernardi Schneider; Michael V Callahan; Jill Glasspool-Malone; Robert Malone
Journal:  PLoS Negl Trop Dis       Date:  2016-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.